--- title: "ZAWYA-PRESSR: Burjeel Medical City launches Sarcoma & Bone Center to strengthen care for rare and complex cancers" type: "News" locale: "en" url: "https://longbridge.com/en/news/275995782.md" description: "Burjeel Cancer Institute has launched a specialized Sarcoma & Bone Center at Burjeel Medical City in Abu Dhabi, enhancing care for rare and complex cancers. The center integrates various specialties, including medical and orthopedic oncology, to provide coordinated, personalized treatment plans. Equipped with advanced technologies, it aims to improve survival rates and reduce recurrence through evidence-based care. This initiative aligns with the UAE's vision for a competitive healthcare system focused on quality and innovation, reinforcing Burjeel's position as a regional leader in specialized oncology services." datetime: "2026-02-15T05:30:33.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/275995782.md) - [en](https://longbridge.com/en/news/275995782.md) - [zh-HK](https://longbridge.com/zh-HK/news/275995782.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275995782.md) | [繁體中文](https://longbridge.com/zh-HK/news/275995782.md) # ZAWYA-PRESSR: Burjeel Medical City launches Sarcoma & Bone Center to strengthen care for rare and complex cancers **Abu Dhabi:** Burjeel Cancer Institute (BCI), one of the largest cancer care networks in the UAE, has announced the launch of its specialized Sarcoma & Bone Center at Burjeel Medical City (BMC), the flagship facility of Burjeel Holdings in Abu Dhabi. The center has been established in collaboration with the Burjeel Orthopaedic Institute to enhance the diagnosis and treatment of rare and complex bone and soft tissue tumors. The newly launched center brings together medical oncology, orthopedic oncology, radiation oncology, vascular surgery, radiology, rehabilitation medicine, and psychological support services within a single integrated framework. Patients benefit from coordinated care delivered by a multidisciplinary team, ensuring personalized treatment plans from diagnosis through recovery. The new center represents a major addition to highly specialized subspecialty care, reinforcing the United Arab Emirates’ position as a regional and global hub for innovation and specialized oncology services. Sarcomas are among the rarest forms of cancer, accounting for approximately 1 percent of adult cancers and nearly 15 percent of pediatric cancers. Globally, more than 13,000 new cases are reported each year. Studies show that early diagnosis and treatment at specialized centers significantly improve survival outcomes. The facility is equipped with advanced technologies, including PET-CT imaging, intraoperative MRI, limb-salvage microsurgery, and access to targeted therapies and immunotherapies supported by advanced genomic analysis. The center also utilizes Next-Generation Sequencing and high-resolution imaging to tailor treatment strategies based on each patient’s clinical and genetic profile. “Our goal is to provide patients with access to specialized expertise and advanced treatment options closer to home. By bringing together oncology, surgery, diagnostics, rehabilitation, and psychosocial support in one center, we are improving the patient journey and supporting better outcomes for those affected by rare cancers,” said Professor Humaid Al Shamsi, CEO of BCI. He added that Burjeel Cancer Institute continues to expand its network across Abu Dhabi, Dubai, Sharjah, Al Ain, and the Sultanate of Oman to ensure broader access to specialized oncology services. Through scientific collaboration and adherence to international treatment guidelines, including those set by leading global oncology societies, the center aims to improve five-year survival rates and reduce recurrence by offering specialized, evidence-based care. Dr. Mujtaba Ali Khan, CEO BMC, said the new center aligns with the hospital’s commitment to advancing highly specialized care. “This launch reinforces our investment in world-class infrastructure, advanced technology, and expert clinical teams. It also supports the UAE’s vision of building a globally competitive healthcare system focused on quality, innovation, and patient-centered care,” he said. Dr. Mohammed Muath Adi, Consultant Orthopedic Surgeon and Head of the Burjeel Orthopaedic Institute, emphasized the importance of a unified approach to treating musculoskeletal cancers. “Managing sarcoma requires close coordination between multiple specialties. By offering comprehensive services under one roof, we are able to deliver timely diagnosis, advanced surgical techniques, and structured rehabilitation plans that enhance quality of life and long-term outcomes for our patients,” he said. With the launch of the Sarcoma & Bone Center, BCI further strengthens its position as a regional destination for complex and subspecialized cancer care. Send us your press releases to pressrelease.zawya@lseg.com Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release. The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk. To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages. ## Related News & Research - [This Nutanix Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday](https://longbridge.com/en/news/281550938.md) - [09:36 ETFlorida Cancer Specialists & Research Institute Welcomes Nikita Jain, MD to Practice](https://longbridge.com/en/news/281379951.md) - [12:39 ETThe Mark Foundation for Cancer Research and Samuel Waxman Cancer Research Foundation Merger Finalized](https://longbridge.com/en/news/281402550.md) - [Kennedy sidelining of US advisory panel delays updates to cancer screening guidelines](https://longbridge.com/en/news/281503258.md) - [05:55 ETNew Paper in Translational Insights Presents a Unifying Theory for How the Immune System Recognizes Cancer](https://longbridge.com/en/news/281502039.md)